A cognitive occupation-based programme for people with multiple sclerosis: A new occupational therapy cognitive rehabilitation intervention.
Sinéad M Hynes, Susan Forwell
PMID 31217761WHAT IT FOUND
People with MS and occupational therapists liked a proposed group programme for MS cognition, calling it a good fit.
They said start it soon after diagnosis, but distance, caseloads and small group numbers could block delivery.
Key findings
01All participants responded positively to the COB-MS, and many described the handbook and intervention as a good fit for their daily difficulties.
02Both groups said the programme would have most impact if offered soon after diagnosis.
03Occupational therapists said distance, heavy caseloads and difficulty filling a group would make delivery hard in current services.
STILL TO COME
How it was doneWhat they foundWhat it means for OTs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
The study consulted only seven occupational therapists and five people with MS, so views may not represent wider populations. All participants were female, and the MS group was narrow in age and education, so male and different-stage views are missing. No newly diagnosed people were included, although participants recommended early delivery. Data saturation was likely not reached for people with MS after one focus group in one location. Transcripts were not returned to participants for checking. Participants volunteered after seeing posters, Facebook, or email, so those most interested may be over-represented. The study reports acceptability and implementation views, not outcomes, so it cannot show whether COB-MS helps cognition or daily life.
Declared interests
The study was funded by a National Multiple Sclerosis Society Postdoctoral Fellowship Award and a University of British Columbia Occupational Science & Occupational Therapy Research Initiative Fund Seed Award. The paper does not report other author conflicts of interest.
The easy way to misread this
Do not read this as evidence that COB-MS improves cognition or daily function. It was a small consultation study, and it reports views on acceptability and delivery, not patient outcomes.